Skip to main content

Table 4 Mean change in TSAT and serum ferritin over time by CKD stage

From: Ferumoxytol versus iron sucrose treatment: a post-hoc analysis of randomized controlled trials in patients with varying renal function and iron deficiency anemia

CKD Stage

TSAT, % (SD)

Ferritin, μg/L (SD)

Ferumoxytol Treatment Group

Iron Sucrose Treatment Group

Ferumoxytol Treatment Group

Iron Sucrose Treatment Group

Stage 1 (eGFR ≥90 mL/min)

(n = 280)

(n = 126)

(n = 280)

(n = 126)

Baseline

5.8 (11.25)

4.3 (5.21)

14.1 (39.76)

15.4 (53.11)

Week 2

26.1 (19.59)

15.8 (11.90)

291.1 (192.69)

172.5 (245.93)

Week 3

24.1 (11.54)

19.8 (15.38)

179.7 (157.02)

157.3 (211.08)

Week 4

22.7 (10.95)

19.2 (13.81)

123.7 (124.20)

124.0 (211.93)

Week 5

22.9 (21.75)

19.1 (14.77)

98.3 (118.96)

96.4 (185.27)

Stage 2 (eGFR 60 to <90 mL/min)

(n = 104)

(n = 59)

(n = 104)

(n = 59)

Baseline

6.6 (5.7)

5.1 (3.47)

55.4 (138.26)

22.7 (80.21)

Week 2

26.2 (11.41)

25.8 (51.56)

442.0 (398.63)

215.0 (226.93)

Week 3

24.3 (10.39)

17.2 (7.81)

325.6 (385.93)

196.6 (212.70)

Week 4

23.9 (11.17)

18.9 (12.46)

277.9 (394.82)

166.2 (254.32)

Week 5

22.5 (10.35)

16.5 (6.66)

247.2 (471.24)

127.5 (214.99)

Stage 3 (eGFR 30 to <60 mL/min)

(n = 41)

(n = 33)

(n = 41)

(n = 33)

Baseline

13.4 (18.31)

16.1 (22.18)

106.6 (168.37)

106.5 (157.15)

Week 2

26.6 (13.27)

21.8 (22.81)

629.3 (507.21)

338.6 (296.76)

Week 3

25.0 (11.45)

18.9 (8.16)

518.1 (425.74)

373.0 (321.68)

Week 4

23.2 (11.01)

19.2 (7.78)

452.5 (443.14)

314.8 (284.35)

Week 5

23.1 (12.15)

19.4 (7.86)

426.0 (433.68)

312.0 (284.41)

Stage 4 (eGFR 15 to <30 mL/min)

(n = 23)

(n = 20)

(n = 23)

(n = 20)

Baseline

21.7 (19.41)

17.0 (6.49)

152.3 (123.03)

141.4 (158.16)

Week 2

30.6 (9.71)

24.3 (7.14)

720.7 (280.38)

520.2 (244.56)

Week 3

28.6 (13.22)

24.0 (5.85)

632.8 (324.78)

529.6 (244.92)

Week 4

32.2 (15.81)

25.7 (7.18)

552.4 (327.53)

440.5 (228.45)

Week 5

26.3 (6.34)

23.1 (5.79)

514.6 (285.12)

407.0 (231.30)

Stage 5 (eGFR <15 mL/min)

(n = 38)

(n = 42)

(n = 38)

(n = 42)

Baseline

22.3 (12.91)

21.7 (14.76)

411.3 (348.97)

359.7 (287.65)

Week 2

34.6 (16.18)

25.4 (12.87)

915.8 (372.92)

603.4 (338.87)

Week 3

32.2 (12.81)

24.7 (7.44)

959.0 (605.92)

675.2 (339.54)

Week 4

30.4 (12.57)

27.7 (13.27)

831.7 (452.94)

682.2 (391.21)

Week 5

28.7 (8.82)

27.9 (15.80)

788.4 (427.21)

618.9 (355.47)

  1. CKD chronic kidney disease, GFR glomerular filtration rate, SD standard deviation, TSAT transferrin saturation